December 1999
Many health care organizations that had reached for the brass ring are now wringing their hands as they file for Chapter 11. All is not lost, however.
Cost pressures that plans associate with rising drug expenditures result partly from their own largesse. Solutions: Restore consumerism and forge a common agenda with drug companies.
This former journalist is participating in one of the biggest stories of our time: Helping health plans and physicians locate that elusive point where doing the right thing and maximizing bottom lines intersect.
They're young, they're hungry, and they claim to be approaching business problems from a different angle. Will these entrepreneurs succeed?
United HealthCare's move to make advance authorization "obsolete" generated headlines. Inside the industry, however, the reaction was muted.
Compensation Monitor
Editor's Memo
Managed Care Outlook
State Initiatives
Washington Watch
Follow us
Today's popular content
- How Doctors Are Paid Now, And Why It Has to Change
- Specialty Pharmacy Management Will Become More Intense
- What the Primary Care Physician Shortage Means for Health Plans
- Occupy the OR
- Through the Looking Glass
- Transparency Called Key To Uniting Cost Control, Quality Improvement
- Health Plans Can Learn From VHA Turnaround
- It's To Plans' Benefit To Spell Out Authority
- Large employers agree on rewarding healthy behavior
- Insurers skeptical of usefulness of companion diagnostics
Recent blog posts
- Health Care Industry’s Moment of Truth Is Approaching
- Through the Looking Glass
- Physician Practices Hiring Care Coordinators
- Who Will Pay for High-Cost Biologics?
- Health exchanges stumble to the starting line
- It's Elementary
- Yet Another Warning About Antibiotic Overprescribing
- Let the EMR Backlash Begin
- Not a Third World Experience
- UK: Health Care Policy Mayhem…and a Very Public Scandal
